Antitumor activity and antioxidant status of Caesalpinia bonducella against Ehrlich ascites carcinoma in Swiss albino mice

被引:143
作者
Gupta, M [1 ]
Mazumder, UK [1 ]
Kumar, RS [1 ]
Sivakumar, T [1 ]
Vamsi, MLM [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Div Phamacol & Pharmaceut Chem, Kolkata 700032, W Bengal, India
关键词
Caesalpinia bonducella; Ehrlich ascites carcinoma; hematological parameter; antioxidant; antitumor activity;
D O I
10.1254/jphs.94.177
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The methanol extract of Caesalpinia bonducella FLEMING (Caesalpiniaceae) leaves (MECB) were evaluated for antitumor activity against Ehrlich ascites carcinoma (EAC)-bearing Swiss albino mice. The extract was administered at the doses of 50, 100, and 200 mg/kg body weight per day for 14 days after 24 h of tumor inoculation. After the last dose and 18 h fasting, the mice were sacrificed. The present study deals with the effect of MECB on the growth of transplantable murine tumor, life span of EAC-bearing hosts, hematological profile, and biochemical parameters such as lipid peroxidation (LPO), glutathione content (GSH), superoxide dismutase (SOD), and catalase (CAT) activities. MECB caused significant (P<0.01) decrease in tumor volume, packed cell volume, and viable cell count; and it prolonged the life span of EAC-tumor bearing mice. Hematological profile converted to more or less normal levels in extract-treated mice. MECB significantly (P<0.05) decreased the levels of lipid peroxidation and significantly (P<0.05) increased the levels of GSH, SOD, and CAT. The MECB was found to be devoid of conspicuous short-term toxicity in the mice when administered daily (i.p.) for 14 days at the doses of 50, 100, 200, and 300 mg/kg. The treated mice showed conspicuous toxic symptoms only at 300 mg/kg. The results indicate that MECB exhibited significant antitumor and antioxidant activity in EAC-bearing mice.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 49 条
[1]  
Adesina S. K., 1982, Fitoterapia, V53, P147
[2]  
[Anonymous], 1983, METHODS ENZYMATIC AN
[3]  
[Anonymous], CANCER RES
[4]  
[Anonymous], 1987, FUNDAMENTALS CLIN CH
[5]  
BERGMEYER HU, 1978, CLIN CHEM, V24, P58
[6]  
CLARKSON B D, 1965, Prog Clin Cancer, V10, P625
[7]  
D'Armour F. E., 1965, MANUAL LAB WORK MAMM, P4
[8]  
Dacie JV, 1958, PRACTICAL HEMATOLOGY, P38
[9]   Ginkgo biloba extracts and cancer:: a research area in its infancy [J].
DeFeudis, FV ;
Papadopoulos, V ;
Drieu, K .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2003, 17 (04) :405-417
[10]  
DEWYS WD, 1982, CANCER RES, V42, pS721